» Articles » PMID: 20211134

Protein Dynamics in Drug Combinations: a Linear Superposition of Individual-drug Responses

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2010 Mar 10
PMID 20211134
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Drugs and drug combinations have complex biological effects on cells and organisms. Little is known about how drugs affect protein dynamics that determine these effects. Here, we use a dynamic proteomics approach to accurately follow 15 protein levels in human cells in response to 13 different drugs. We find that protein dynamics in response to combinations of drugs are described accurately by a linear superposition (weighted sum) of their response to individual drugs. The weights in this superposition describe the relative impact of each drug on each protein. Using these weights, we show that one can predict the dynamics in a three-drug or four-drug combination on the basis of the dynamics in drug pairs. Our approach might eliminate the need to increase the number of experiments exponentially with the number of drugs and suggests that it might be possible to rationally control protein dynamics with specific drug combinations.

Citing Articles

High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line.

Wang S, Oliveira-Silveira J, Fang G, Kang J BMC Cancer. 2024; 24(1):335.

PMID: 38475728 PMC: 11542337. DOI: 10.1186/s12885-024-12057-4.


Review of Predicting Synergistic Drug Combinations.

Pan Y, Ren H, Lan L, Li Y, Huang T Life (Basel). 2023; 13(9).

PMID: 37763281 PMC: 10533134. DOI: 10.3390/life13091878.


D-SPIN constructs gene regulatory network models from multiplexed scRNA-seq data revealing organizing principles of cellular perturbation response.

Jiang J, Chen S, Tsou T, McGinnis C, Khazaei T, Zhu Q bioRxiv. 2023; .

PMID: 37131803 PMC: 10153191. DOI: 10.1101/2023.04.19.537364.


A hybrid deep forest-based method for predicting synergistic drug combinations.

Wu L, Gao J, Zhang Y, Sui B, Wen Y, Wu Q Cell Rep Methods. 2023; 3(2):100411.

PMID: 36936075 PMC: 10014304. DOI: 10.1016/j.crmeth.2023.100411.


Pharmacodynamics and Bactericidal Activity of Combination Regimens in Pulmonary Tuberculosis: Application to Bedaquiline-Pretomanid-Pyrazinamide.

Lyons M Antimicrob Agents Chemother. 2022; 66(12):e0089822.

PMID: 36377952 PMC: 9765268. DOI: 10.1128/aac.00898-22.